The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1984-12

AUTHORS

Angus G. Dalgleish, Peter C. L. Beverley, Paul R. Clapham, Dorothy H. Crawford, Melvyn F. Greaves, Robin A. Weiss

ABSTRACT

Acquired immune deficiency syndrome (AIDS) is characterized by opportunistic infections and by 'opportunistic neoplasms' (for example, Kaposi's sarcoma). Persistent generalized lymphadenopathy (PGL) is epidemiologically associated with AIDS, especially in male homosexuals. A subset of T lymphocytes positive for the CD4 antigen (also termed T4 antigen), is depleted in AIDS and PGL patients. A retrovirus found in T-cell cultures from these patients is strongly implicated in the aetiology of AIDS because of the high frequency of isolation and the prevalence of specific antibodies in the patients. Here we have detected cell-surface receptors for the AIDS retrovirus (human T-cell leukaemia virus-III (HTLV-III) and lymphadenopathy-associated virus-1 (LAV-1) isolates) by testing the susceptibility of cells to infection with pseudotypes of vesicular stomatitis virus bearing retroviral envelope antigens, and by the formation of multinucleated syncytia on mixing virus-producing cells with receptor-bearing cells. Receptors were present only on cells expressing CD4 antigen; among 155 monoclonal antibodies tested, each of the 14 anti-CD4 antibodies inhibited formation of syncytia and blocked pseudotypes. Productive infection of CD4+ cells with HTLV-III or LAV-1 markedly reduced cell-surface expression of CD4. In contrast, receptors for HTLV-I and HTLV-II were not restricted to CD4+ cells, were not blocked by anti-CD4 antibodies; cells productively infected with HTLV-I and HTLV-II expressed surface CD4. Hence, we conclude that the CD4 antigen is an essential and specific component of the receptor for the causative agent of AIDS. More... »

PAGES

763-767

References to SciGraph publications

Journal

TITLE

Nature

ISSUE

5996

VOLUME

312

Related Patents

  • Methods Of Inhibiting Human Immunodeficiency Virus Type 1 (Hiv-1) Infection Through The Administration Of Ccr5 Chemokine Receptor Antagonists
  • Isolated Peptides Derived From Human Immunodeficiency Virus Types 1 And 2 Containing Fusion Inhibitory Domains
  • Methods For Chemically Synthesizing Immunoglobulin Chimeric Proteins
  • Methods Of Inhibiting Human Immunodeficiency Virus Infection Through The Administration Of Synergistic Combinations Of Anti-Ccr5 Monoclonal Antibodies, Fusion Inhibitors, And Cd4-Gp120 Binding Inhibitors
  • Methods For The Inhibition Of Epstein-Barr Virus Transmission Employing Anti-Viral Peptides Capable Of Abrogating Viral Fusion And Transmission
  • Clotting Factor-Fc Chimeric Proteins To Treat Hemophilia
  • Pharmaceutical Being Used For Treating Hiv Infection, The Composition And Uses Thereof
  • Anti-Cd4 Antibody Homologs Useful In Prophylaxis And Treatment Of Aids, Arc And Hiv Infection
  • Nucleic Acids Encoding Self-Assembled, Non-Infectious, Non-Replicating, Immunogenic Retrovirus-Like Particles Comprising Modified Hiv Genomes And Chimeric Envelope Glycoproteins
  • Human Monoclonal Antibodies Directed Against The Transmembrane Glycoprotein (Gp41) Of Human Immunodeficiency Virus-1 (Hiv-1)
  • Targeted Cytolysis Of Hiv-Infected Cells By Chimeric Cd4 Receptor-Bearing Cells
  • Targeted Cytolysis Of Hiv-Infected Cells By Chimeric Cd4 Receptor-Bearing Cells
  • Method Of Raising Neutralizing Antibodies Against Hiv
  • Cvn-12p1: A Recombinant Allosteric Lectin Antagonist Of Hiv-1 Envelope Gp120 Interactions
  • Compounds And Method Of Identifying, Synthesizing, Optimizing And Profiling Protein Modulators
  • Dual Inhibitors Of Hiv-1 Gp-120 Interactions
  • Microfluidic Particle-Analysis Systems
  • Inhibition Of Hiv-1 Replication By Disruption Of The Processing Of The Viral Capsid-Spacer Peptide 1 Protein
  • Anti-Ccr5 Antibody
  • Authentic Trimeric Hiv-1 Gp140 Envelope Glycoproteins Comprising A Long Linker And Tag
  • Immunoglobulin Chimeric Monomer-Dimer Hybrids
  • Combined Therapy For Treatment Of Hiv Infection
  • Immunoglobulin Chimeric Monomer-Dimer Hybrids
  • Redirection Of Cellular Immunity By Protein Tyrosine Kinase Chimeras
  • Methods For Assaying Inhibition Of Hiv-1 Envelope Glycoprotein-Mediated Membrane Fusion
  • Human Immunodeficiency Virus Type 1 (Hiv-1)-Neutralizing Human Single-Chain Antibodies With Improved Breadth And Potency
  • Identification Of Novel Broadly Cross-Reactive Neutralizing Human Monoclonal Antibodies Using Sequential Antigen Panning Of Phage Display Libraries
  • Methods For Inhibition Of Membrane Fusion-Associated Events, Including Respiratory Syncytial Virus Transmission
  • Method Of Purifying Authentic Trimeric Hiv-1 Gp140 Envelope Glycoproteins Comprising A Long Linker And Tag
  • Compounds And Method Of Identifying, Synthesizing, Optimizing And Profiling Protein Modulators
  • Designing A Soluble Full-Length Hiv-1 Gp41 Trimer
  • Approach To Produce Hiv-1 Gp140 Envelope Protein Trimers
  • Population Of T4-Lymphocytes Specific For The Lav-Virus, Method For Their Production And Their Use In The Production Of This Virus
  • Methods For Inhibition Of Membrane-Fusion-Associated Events, Including Hepatitis B Virus Transmission
  • Immunoglobulin Chimeric Monomer-Dimer Hybrids
  • Anti-Ccr5 Antibody
  • Compositions For Inhibition Of Membrane Fusion-Associated Events, Including Influenza Virus Transmission
  • Neutralizing Antibodies Against Hiv Infection
  • Antibodies Against A Host Cell Antigen Complex For Pre And Post Exposure Protection From Infection By Hiv
  • Self-Assembled, Non-Infectious, Non-Replicating; Immunogenic Retrovirus-Like Particles Comprising Modified Hiv Genomes Devoid Of Long Terminal Repeats And Chimeric Envelope Glycoproteins
  • Small Peptides Which Inhibit Binding To T-4 Receptors And Act As Immunogens
  • Hiv Immunogenic Complexes
  • Peptide Vaccines And Associated Methods For Protection Against Feline Leukemia Virus
  • Human Monoclonal Antibodies Directed Against The Transmembrane Glycoprotein (Gp41) Of Human Immunodeficiency Virus-1 (Hiv-1)
  • In The Visible Antigens Glycoprotein Of The Envelope Of The Aids Virus, In Particular Of The Precursors Glycoprotein, Of Obtaining These Antigens And Means Employed In These 1995, Applications Of These Compositions For The Preparation Of Antigens Immunogenic Or For The Diagnosis Of Aids Or Of Conditions Which Are Related
  • Methods For Inhibition Of Membrane Fusion-Associated Events, Including Hiv Transmission
  • Multifunctional Self-Assembling Polymeric Nanosystems
  • Small Peptides Which Inhibit Binding To T-4 Receptors And Act As Immunogens
  • Derivatives Of Soluble T-4
  • Redirection Of Cellular Immunity By Protein Tyrosine Kinase Chimeras
  • Monoclonal Antibody Against The Ccr5 Chemokine Receptor
  • Human Immunodeficiency Virus-Neutralizing Human Antibodies With Improved Breadth And Potency
  • Monoclonal Antibodies And Fv Specific For Cd2 Antigen
  • Population Of The T4 Lymphocytes Specific Lav, Their Process Of Preparation And Their Application To The Production Of This Virus.
  • Herpes Virus Entry Receptor Protein
  • Broadly Cross-Reactive Neutralizing Antibodies Against Human Immunodeficiency Virus Selected By Env-Cd4-Co-Receptor Complexes
  • Simian Immunodeficiency Virus Peptides With Antifusogenic And Antiviral Activities
  • Chemokines That Inhibit Immunodeficiency Virus Infection And Methods Based Thereon
  • The Retrovirus Siv Cpz-Ant And Its Uses
  • Approach To Produce Hiv-1 Gp140 Envelope Protein Trimers
  • Ccr5 Chemokine Receptor-Specific Monoclonal Antibodies Capable Of Inhibiting Hiv-1 Cell Fusion
  • Compositions And Methods For The Detection Of Hiv-1/Hiv-2 Infection.
  • Anti-Ccr5 Antibody
  • Methods For Inhibiting Hiv-1 Envelope Glycoprotein-Medicated Membrane Fusion
  • Methods And Compositions For Treatment Of Hiv-1 Infection Using Antiviral Compounds In Simultaneous Or Sequential Combinations
  • Compositions And Methods For Inhibition Of Hiv-1 Infection
  • Suppressor Of Hiv Replication And Transcription
  • Herpes Virus Entry Receptor Protein
  • Methods For The Identification Of Compounds Capable Of Inhibiting Hiv-1 Viral Replication Employing Murine Cell Lines Expressing Human Topoisomerase I
  • Targeted Cytolysis Of Hiv-Infected Cells By Chimeric Cd4 Receptor-Bearing Cells
  • Antibody To Herpes Virus Entry Receptor Protein
  • Chimeric Viral-Neutralizing Immunoglobulins
  • Synthetic Peptide Inhibitors Of Hiv Transmission
  • Clotting Factor-Fc Chimeric Proteins To Treat Hemophilia
  • Immunogenic Compositions Derived From Structural Alteration Of Hiv Envelope Proteins
  • Polymorphs Of 3-O-(3′,3′-Dimethylsuccinyl)Betulinic Acid Di-N-Methyl-D-Glucamine
  • Dual Inhibitors Of Hiv-1 Gp-120 Interactions
  • Macrophage Derived Chemokine (Mdc) As An Anti-Viral Agent For The Treatment And Prevention Of Lentivirus Infection
  • Chemokine Inhibition Of Immunodeficiency Virus
  • Monocytoid Cell Line, Its Production And Method For Infection With Virus, Especially Hiv
  • Population Of T4 Lymphocytes Specific Of Lav Virus, Process For Obtaining Them And Their Application To The Production Of Said Virus
  • A Method Of Detecting Infectious Aids Virus
  • Methods And Compositions For Inhibition Of Membrane Fusion-Associated Events, Including Hiv Transmission
  • Pharmaceutical Used For Treating Hiv Infection, The Composition And Uses Thereof
  • Methods For Inhibiting The Production Of Hiv-1 Retrovirus Using Monoclonal Antibodies And Fv Specific For Cd2 Antigen
  • Redirection Of Cellular Immunity By Protein Tyrosine Kinase Chimeras
  • Human Monoclonal Antibodies Directed Against The Transmembrane Glycoprotein (Gp41) Of Human Immunodeficiency Virus-1 (Hiv-1)
  • Monoclonal Antibodies Which Neutralize Hiv-1 Infection
  • Monoclonal Antibodies And Fv Specific For Cd2 Antigen
  • Hiv Immunogenic Complexes
  • Fusion Proteins Comprising Cd4 And The Malaria Parasite Merozoite Glycophorin Binding Protein 130 (Gbp-130)
  • Dual Inhibitors Of Hiv-1 Gp-120 Interactions
  • Human Monoclonal Antibodies Directed Against The Transmembrane Glycoprotein (Gp41) Of Human Immunodeficiency Virus-1 (Hiv-1) And Detection Of Antibodies Against Epitope (Gcsgklic)
  • Compositions And Methods For Inhibiting Human Immunodeficiency Virus Infection By Down-Regulating Human Cellular Genes
  • Theramutein Modulators
  • Human Respiratory Syncytial Virus Peptides With Antifusogenic And Antiviral Activities
  • Fusion Proteins Comprising Dp-178 And Other Viral Fusion Inhibitor Peptides Useful For Treating Aids
  • Method Of Purifying Authentic Trimeric Hiv-1 Envelope Glycoproteins Comprising A Long Linker And Tag
  • Compounds And Method Of Identifying, Synthesizing, Optimizing And Profiling Protein Modulators
  • Methods And Compositions For Inhibition Of Membrane Fusion-Associated Events Including Rsv Transmission
  • Therameutin Modulators
  • Designing A Soluble Full-Length Hiv-1 Gp41 Trimer
  • Methods For Inhibiting Hiv-1 Replication Involving The Administration Of An Anti-Ccr5 Receptor Monoclonal Antibody And Small Molecule Ccr5 Receptor Antagonist
  • Small Peptides Which Inhibit Binding To T-4 Receptors
  • Authentic Trimeric Hiv-1 Envelope Glycoproteins Comprising A Long Linker And Tag
  • The Retrovirus Siv Cpz-Ant And Its Uses
  • Immunoglobulin Chimeric Monomer-Dimer Hybrids
  • Theramutein Modulators
  • Nucleic Acids Encoding Dp-178 And Other Viral Fusion Inhibitor Peptides Useful For Treating Aids
  • Antigens Related To The Envelope Glycoprotein Of The Acquired Immunodeficiency Syndrome Virus
  • Methods For Identification Of Cds8+ Suppressor Molecules
  • Methods And Compositions For Inhibition Of Membrane Fusion-Associated Events, Including Hiv Transmission
  • Substituted 3′,4′-Di-O-Camphanoyl-(+)-Cis-Khellactone Analogs, Compositions Thereof, And Methods For Using Thereof
  • Hiv Immunogenic Complexes Comprising Gp120 Covalently Bound To Cd4 Or Concanavalin A
  • Compositions For Inhibition Of Membrane Fusion-Associated Events, Including Human Parainfluenza Virus Transmission
  • Measles Virus Peptides With Antifusogenic And Antiviral Activities
  • Treatment Of Hiv And Other Viral Infections Using Combinatorial Therapy
  • Suppressor Of Hiv-1 Replication And Transcription
  • Assay For Detection Of Viral Fusion Inhibitors
  • Acylated Betulin And Dihydrobetulin Derivatives, Preparation Thereof And Use Thereof
  • Vectors Expressing Hybrid Viruses, Methods Of Use And Novel Assays
  • Antifusogenic Proteins Comprising Human Immunodeficiency Virus Type 1 (Hiv-1) Gp41 Dp-178 Polypeptide Variants And A Macromolecular Carrier
  • Anti-Ccr5 Antibody
  • Immunoassay Diagnostic Kit Containing Antigens Derived From Self-Assembled, Non-Infectious, Non-Replicating, Immunogenic Retrovirus-Like Particles Comprising Modified Hiv Genomes And Chimeric Envelope Glycoproteins
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/312763a0

    DOI

    http://dx.doi.org/10.1038/312763a0

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1021684259

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/6096719


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Immunology", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Acquired Immunodeficiency Syndrome", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antibodies, Monoclonal", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antigens, Surface", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Deltaretrovirus", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Receptors, Virus", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "T-Lymphocytes", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Vesicular stomatitis Indiana virus", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "familyName": "Dalgleish", 
            "givenName": "Angus G.", 
            "id": "sg:person.01040665311.03", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01040665311.03"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "Beverley", 
            "givenName": "Peter C. L.", 
            "id": "sg:person.01060575403.86", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01060575403.86"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "Clapham", 
            "givenName": "Paul R.", 
            "id": "sg:person.0636250107.14", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636250107.14"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "Crawford", 
            "givenName": "Dorothy H.", 
            "id": "sg:person.0754431446.33", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0754431446.33"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "Greaves", 
            "givenName": "Melvyn F.", 
            "id": "sg:person.013377471142.72", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013377471142.72"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "Weiss", 
            "givenName": "Robin A.", 
            "id": "sg:person.011763114607.07", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011763114607.07"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "https://doi.org/10.1084/jem.159.3.783", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1004778935"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1073/pnas.80.22.7006", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1009595142"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/ijc.2910320310", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012384017"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1073/pnas.80.17.5402", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014668374"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1073/pnas.81.9.2886", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017404056"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/312767a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028751316", 
              "https://doi.org/10.1038/312767a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/ijc.2910170504", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1029291418"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1073/pnas.79.14.4395", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1039504957"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1073/pnas.80.23.7337", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043653897"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1172/jci111190", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1048403649"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1073/pnas.81.14.4510", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051912242"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1099/0022-1317-15-3-183", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1060351367"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1126/science.6089333", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1062634069"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1126/science.6189183", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1062635034"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1126/science.6200935", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1062635710"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1126/science.6200936", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1062635711"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1126/science.6200937", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1062635712"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1126/science.6316502", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1062636728"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1126/science.6328660", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1062636799"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1126/science.6328661", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1062636800"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1126/science.6967228", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1062641958"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1126/science.7053569", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1062643385"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1077152246", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1081622677", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1081628048", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1081706316", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1081728484", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1081732189", 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1984-12", 
        "datePublishedReg": "1984-12-01", 
        "description": "Acquired immune deficiency syndrome (AIDS) is characterized by opportunistic infections and by 'opportunistic neoplasms' (for example, Kaposi's sarcoma). Persistent generalized lymphadenopathy (PGL) is epidemiologically associated with AIDS, especially in male homosexuals. A subset of T lymphocytes positive for the CD4 antigen (also termed T4 antigen), is depleted in AIDS and PGL patients. A retrovirus found in T-cell cultures from these patients is strongly implicated in the aetiology of AIDS because of the high frequency of isolation and the prevalence of specific antibodies in the patients. Here we have detected cell-surface receptors for the AIDS retrovirus (human T-cell leukaemia virus-III (HTLV-III) and lymphadenopathy-associated virus-1 (LAV-1) isolates) by testing the susceptibility of cells to infection with pseudotypes of vesicular stomatitis virus bearing retroviral envelope antigens, and by the formation of multinucleated syncytia on mixing virus-producing cells with receptor-bearing cells. Receptors were present only on cells expressing CD4 antigen; among 155 monoclonal antibodies tested, each of the 14 anti-CD4 antibodies inhibited formation of syncytia and blocked pseudotypes. Productive infection of CD4+ cells with HTLV-III or LAV-1 markedly reduced cell-surface expression of CD4. In contrast, receptors for HTLV-I and HTLV-II were not restricted to CD4+ cells, were not blocked by anti-CD4 antibodies; cells productively infected with HTLV-I and HTLV-II expressed surface CD4. Hence, we conclude that the CD4 antigen is an essential and specific component of the receptor for the causative agent of AIDS.", 
        "genre": "research_article", 
        "id": "sg:pub.10.1038/312763a0", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1018957", 
            "issn": [
              "0090-0028", 
              "1476-4687"
            ], 
            "name": "Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "5996", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "312"
          }
        ], 
        "name": "The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus", 
        "pagination": "763-767", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "6750439c58a85b646f1fc4a223b3b1aae5b305dd62036f78de139f7804987cbc"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "6096719"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "0410462"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/312763a0"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1021684259"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/312763a0", 
          "https://app.dimensions.ai/details/publication/pub.1021684259"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-11T00:03", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8695_00000424.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "http://www.nature.com/nature/journal/v312/n5996/full/312763a0.html"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/312763a0'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/312763a0'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/312763a0'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/312763a0'


     

    This table displays all metadata directly associated to this object as RDF triples.

    206 TRIPLES      21 PREDICATES      65 URIs      29 LITERALS      17 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/312763a0 schema:about N0a7a8377bf4c4fc28db93c8ac2be2756
    2 N45f67e291fba43f38f9073d303596193
    3 N5dfb6f58004f449caa763d380a882e67
    4 N7413df710adf43ea90372c2f85589abd
    5 Na5d226fc8fe541139384a0f47fbb3699
    6 Na7c67854bc584bdba218a009820158c1
    7 Nc1dc876b9ef8403a90a31be8f45f5205
    8 Nffa2876b66fe4756838ead6c122b06f9
    9 anzsrc-for:11
    10 anzsrc-for:1107
    11 schema:author N5a640f0bdff546bbb2a1a0dac6bf5b3b
    12 schema:citation sg:pub.10.1038/312767a0
    13 https://app.dimensions.ai/details/publication/pub.1077152246
    14 https://app.dimensions.ai/details/publication/pub.1081622677
    15 https://app.dimensions.ai/details/publication/pub.1081628048
    16 https://app.dimensions.ai/details/publication/pub.1081706316
    17 https://app.dimensions.ai/details/publication/pub.1081728484
    18 https://app.dimensions.ai/details/publication/pub.1081732189
    19 https://doi.org/10.1002/ijc.2910170504
    20 https://doi.org/10.1002/ijc.2910320310
    21 https://doi.org/10.1073/pnas.79.14.4395
    22 https://doi.org/10.1073/pnas.80.17.5402
    23 https://doi.org/10.1073/pnas.80.22.7006
    24 https://doi.org/10.1073/pnas.80.23.7337
    25 https://doi.org/10.1073/pnas.81.14.4510
    26 https://doi.org/10.1073/pnas.81.9.2886
    27 https://doi.org/10.1084/jem.159.3.783
    28 https://doi.org/10.1099/0022-1317-15-3-183
    29 https://doi.org/10.1126/science.6089333
    30 https://doi.org/10.1126/science.6189183
    31 https://doi.org/10.1126/science.6200935
    32 https://doi.org/10.1126/science.6200936
    33 https://doi.org/10.1126/science.6200937
    34 https://doi.org/10.1126/science.6316502
    35 https://doi.org/10.1126/science.6328660
    36 https://doi.org/10.1126/science.6328661
    37 https://doi.org/10.1126/science.6967228
    38 https://doi.org/10.1126/science.7053569
    39 https://doi.org/10.1172/jci111190
    40 schema:datePublished 1984-12
    41 schema:datePublishedReg 1984-12-01
    42 schema:description Acquired immune deficiency syndrome (AIDS) is characterized by opportunistic infections and by 'opportunistic neoplasms' (for example, Kaposi's sarcoma). Persistent generalized lymphadenopathy (PGL) is epidemiologically associated with AIDS, especially in male homosexuals. A subset of T lymphocytes positive for the CD4 antigen (also termed T4 antigen), is depleted in AIDS and PGL patients. A retrovirus found in T-cell cultures from these patients is strongly implicated in the aetiology of AIDS because of the high frequency of isolation and the prevalence of specific antibodies in the patients. Here we have detected cell-surface receptors for the AIDS retrovirus (human T-cell leukaemia virus-III (HTLV-III) and lymphadenopathy-associated virus-1 (LAV-1) isolates) by testing the susceptibility of cells to infection with pseudotypes of vesicular stomatitis virus bearing retroviral envelope antigens, and by the formation of multinucleated syncytia on mixing virus-producing cells with receptor-bearing cells. Receptors were present only on cells expressing CD4 antigen; among 155 monoclonal antibodies tested, each of the 14 anti-CD4 antibodies inhibited formation of syncytia and blocked pseudotypes. Productive infection of CD4+ cells with HTLV-III or LAV-1 markedly reduced cell-surface expression of CD4. In contrast, receptors for HTLV-I and HTLV-II were not restricted to CD4+ cells, were not blocked by anti-CD4 antibodies; cells productively infected with HTLV-I and HTLV-II expressed surface CD4. Hence, we conclude that the CD4 antigen is an essential and specific component of the receptor for the causative agent of AIDS.
    43 schema:genre research_article
    44 schema:inLanguage en
    45 schema:isAccessibleForFree false
    46 schema:isPartOf Na0c2e9b180f64affb3dde8b6e800c8e3
    47 Nac0d66c855d44662a67052332db265f3
    48 sg:journal.1018957
    49 schema:name The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
    50 schema:pagination 763-767
    51 schema:productId N0514ffe83610440c8423139bc927f859
    52 N1a71a40f3db04f1cb15468415de2e203
    53 N22041b78a42044f18e22a51a27027b21
    54 N4467830737534f6199e4da75d286c1c3
    55 Na58aa7b267784b9f8aa65fdac6ee5263
    56 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021684259
    57 https://doi.org/10.1038/312763a0
    58 schema:sdDatePublished 2019-04-11T00:03
    59 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    60 schema:sdPublisher N7c2ec9a9f8144c0c8150ae2707674e9a
    61 schema:url http://www.nature.com/nature/journal/v312/n5996/full/312763a0.html
    62 sgo:license sg:explorer/license/
    63 sgo:sdDataset articles
    64 rdf:type schema:ScholarlyArticle
    65 N0514ffe83610440c8423139bc927f859 schema:name doi
    66 schema:value 10.1038/312763a0
    67 rdf:type schema:PropertyValue
    68 N0a7a8377bf4c4fc28db93c8ac2be2756 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    69 schema:name Antigens, Surface
    70 rdf:type schema:DefinedTerm
    71 N1a71a40f3db04f1cb15468415de2e203 schema:name readcube_id
    72 schema:value 6750439c58a85b646f1fc4a223b3b1aae5b305dd62036f78de139f7804987cbc
    73 rdf:type schema:PropertyValue
    74 N22041b78a42044f18e22a51a27027b21 schema:name dimensions_id
    75 schema:value pub.1021684259
    76 rdf:type schema:PropertyValue
    77 N36353ae6059c4c3a86629744d3cac3a6 rdf:first sg:person.0636250107.14
    78 rdf:rest N7777b5329b0d417db08081bafa1a9c98
    79 N4467830737534f6199e4da75d286c1c3 schema:name pubmed_id
    80 schema:value 6096719
    81 rdf:type schema:PropertyValue
    82 N45f67e291fba43f38f9073d303596193 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    83 schema:name Antibodies, Monoclonal
    84 rdf:type schema:DefinedTerm
    85 N4e3ec41ca65e4c7f9e9ede40e4720ae0 rdf:first sg:person.013377471142.72
    86 rdf:rest Na9a02a1f096d49cc8c81d3b4122321a2
    87 N5a640f0bdff546bbb2a1a0dac6bf5b3b rdf:first sg:person.01040665311.03
    88 rdf:rest Nf3f6b4fa574b41aba3f3200940c74de4
    89 N5dfb6f58004f449caa763d380a882e67 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    90 schema:name Vesicular stomatitis Indiana virus
    91 rdf:type schema:DefinedTerm
    92 N7413df710adf43ea90372c2f85589abd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    93 schema:name Acquired Immunodeficiency Syndrome
    94 rdf:type schema:DefinedTerm
    95 N7777b5329b0d417db08081bafa1a9c98 rdf:first sg:person.0754431446.33
    96 rdf:rest N4e3ec41ca65e4c7f9e9ede40e4720ae0
    97 N7c2ec9a9f8144c0c8150ae2707674e9a schema:name Springer Nature - SN SciGraph project
    98 rdf:type schema:Organization
    99 Na0c2e9b180f64affb3dde8b6e800c8e3 schema:issueNumber 5996
    100 rdf:type schema:PublicationIssue
    101 Na58aa7b267784b9f8aa65fdac6ee5263 schema:name nlm_unique_id
    102 schema:value 0410462
    103 rdf:type schema:PropertyValue
    104 Na5d226fc8fe541139384a0f47fbb3699 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    105 schema:name Deltaretrovirus
    106 rdf:type schema:DefinedTerm
    107 Na7c67854bc584bdba218a009820158c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    108 schema:name Humans
    109 rdf:type schema:DefinedTerm
    110 Na9a02a1f096d49cc8c81d3b4122321a2 rdf:first sg:person.011763114607.07
    111 rdf:rest rdf:nil
    112 Nac0d66c855d44662a67052332db265f3 schema:volumeNumber 312
    113 rdf:type schema:PublicationVolume
    114 Nc1dc876b9ef8403a90a31be8f45f5205 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    115 schema:name T-Lymphocytes
    116 rdf:type schema:DefinedTerm
    117 Nf3f6b4fa574b41aba3f3200940c74de4 rdf:first sg:person.01060575403.86
    118 rdf:rest N36353ae6059c4c3a86629744d3cac3a6
    119 Nffa2876b66fe4756838ead6c122b06f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    120 schema:name Receptors, Virus
    121 rdf:type schema:DefinedTerm
    122 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    123 schema:name Medical and Health Sciences
    124 rdf:type schema:DefinedTerm
    125 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
    126 schema:name Immunology
    127 rdf:type schema:DefinedTerm
    128 sg:journal.1018957 schema:issn 0090-0028
    129 1476-4687
    130 schema:name Nature
    131 rdf:type schema:Periodical
    132 sg:person.01040665311.03 schema:familyName Dalgleish
    133 schema:givenName Angus G.
    134 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01040665311.03
    135 rdf:type schema:Person
    136 sg:person.01060575403.86 schema:familyName Beverley
    137 schema:givenName Peter C. L.
    138 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01060575403.86
    139 rdf:type schema:Person
    140 sg:person.011763114607.07 schema:familyName Weiss
    141 schema:givenName Robin A.
    142 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011763114607.07
    143 rdf:type schema:Person
    144 sg:person.013377471142.72 schema:familyName Greaves
    145 schema:givenName Melvyn F.
    146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013377471142.72
    147 rdf:type schema:Person
    148 sg:person.0636250107.14 schema:familyName Clapham
    149 schema:givenName Paul R.
    150 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636250107.14
    151 rdf:type schema:Person
    152 sg:person.0754431446.33 schema:familyName Crawford
    153 schema:givenName Dorothy H.
    154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0754431446.33
    155 rdf:type schema:Person
    156 sg:pub.10.1038/312767a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028751316
    157 https://doi.org/10.1038/312767a0
    158 rdf:type schema:CreativeWork
    159 https://app.dimensions.ai/details/publication/pub.1077152246 schema:CreativeWork
    160 https://app.dimensions.ai/details/publication/pub.1081622677 schema:CreativeWork
    161 https://app.dimensions.ai/details/publication/pub.1081628048 schema:CreativeWork
    162 https://app.dimensions.ai/details/publication/pub.1081706316 schema:CreativeWork
    163 https://app.dimensions.ai/details/publication/pub.1081728484 schema:CreativeWork
    164 https://app.dimensions.ai/details/publication/pub.1081732189 schema:CreativeWork
    165 https://doi.org/10.1002/ijc.2910170504 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029291418
    166 rdf:type schema:CreativeWork
    167 https://doi.org/10.1002/ijc.2910320310 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012384017
    168 rdf:type schema:CreativeWork
    169 https://doi.org/10.1073/pnas.79.14.4395 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039504957
    170 rdf:type schema:CreativeWork
    171 https://doi.org/10.1073/pnas.80.17.5402 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014668374
    172 rdf:type schema:CreativeWork
    173 https://doi.org/10.1073/pnas.80.22.7006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009595142
    174 rdf:type schema:CreativeWork
    175 https://doi.org/10.1073/pnas.80.23.7337 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043653897
    176 rdf:type schema:CreativeWork
    177 https://doi.org/10.1073/pnas.81.14.4510 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051912242
    178 rdf:type schema:CreativeWork
    179 https://doi.org/10.1073/pnas.81.9.2886 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017404056
    180 rdf:type schema:CreativeWork
    181 https://doi.org/10.1084/jem.159.3.783 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004778935
    182 rdf:type schema:CreativeWork
    183 https://doi.org/10.1099/0022-1317-15-3-183 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060351367
    184 rdf:type schema:CreativeWork
    185 https://doi.org/10.1126/science.6089333 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062634069
    186 rdf:type schema:CreativeWork
    187 https://doi.org/10.1126/science.6189183 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062635034
    188 rdf:type schema:CreativeWork
    189 https://doi.org/10.1126/science.6200935 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062635710
    190 rdf:type schema:CreativeWork
    191 https://doi.org/10.1126/science.6200936 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062635711
    192 rdf:type schema:CreativeWork
    193 https://doi.org/10.1126/science.6200937 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062635712
    194 rdf:type schema:CreativeWork
    195 https://doi.org/10.1126/science.6316502 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062636728
    196 rdf:type schema:CreativeWork
    197 https://doi.org/10.1126/science.6328660 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062636799
    198 rdf:type schema:CreativeWork
    199 https://doi.org/10.1126/science.6328661 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062636800
    200 rdf:type schema:CreativeWork
    201 https://doi.org/10.1126/science.6967228 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062641958
    202 rdf:type schema:CreativeWork
    203 https://doi.org/10.1126/science.7053569 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062643385
    204 rdf:type schema:CreativeWork
    205 https://doi.org/10.1172/jci111190 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048403649
    206 rdf:type schema:CreativeWork
     




    Preview window. Press ESC to close (or click here)


    ...